159 related articles for article (PubMed ID: 34675406)
1. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
Chen J; Guanizo A; Luong Q; Jayasekara WSN; Jayasinghe D; Inampudi C; Szczepny A; Garama DJ; Russell PA; Ganju V; Cain JE; Watkins DN; Gough DJ
Oncogene; 2022 Jan; 41(1):138-145. PubMed ID: 34675406
[TBL] [Abstract][Full Text] [Related]
2. FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice.
Ferone G; Song JY; Krijgsman O; van der Vliet J; Cozijnsen M; Semenova EA; Adams DJ; Peeper D; Berns A
Cell Rep; 2020 Mar; 30(11):3837-3850.e3. PubMed ID: 32187553
[TBL] [Abstract][Full Text] [Related]
3. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
[TBL] [Abstract][Full Text] [Related]
4. Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers.
Li J; Wei B; Feng J; Wu X; Chang Y; Wang Y; Yang X; Zhang H; Han S; Zhang C; Zheng J; Groen HJM; van den Berg A; Ma J; Li H; Guo Y
Front Endocrinol (Lausanne); 2022; 13():1006480. PubMed ID: 36583000
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the cell of origin for small cell lung cancer.
Park KS; Liang MC; Raiser DM; Zamponi R; Roach RR; Curtis SJ; Walton Z; Schaffer BE; Roake CM; Zmoos AF; Kriegel C; Wong KK; Sage J; Kim CF
Cell Cycle; 2011 Aug; 10(16):2806-15. PubMed ID: 21822053
[TBL] [Abstract][Full Text] [Related]
6. MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
Mollaoglu G; Guthrie MR; Böhm S; Brägelmann J; Can I; Ballieu PM; Marx A; George J; Heinen C; Chalishazar MD; Cheng H; Ireland AS; Denning KE; Mukhopadhyay A; Vahrenkamp JM; Berrett KC; Mosbruger TL; Wang J; Kohan JL; Salama ME; Witt BL; Peifer M; Thomas RK; Gertz J; Johnson JE; Gazdar AF; Wechsler-Reya RJ; Sos ML; Oliver TG
Cancer Cell; 2017 Feb; 31(2):270-285. PubMed ID: 28089889
[TBL] [Abstract][Full Text] [Related]
7. Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.
Fiorentino FP; Tokgün E; Solé-Sánchez S; Giampaolo S; Tokgün O; Jauset T; Kohno T; Perucho M; Soucek L; Yokota J
Oncotarget; 2016 May; 7(21):31014-28. PubMed ID: 27105536
[TBL] [Abstract][Full Text] [Related]
8. Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung.
Sutherland KD; Proost N; Brouns I; Adriaensen D; Song JY; Berns A
Cancer Cell; 2011 Jun; 19(6):754-64. PubMed ID: 21665149
[TBL] [Abstract][Full Text] [Related]
9. Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling.
Cochrane CR; Vaghjiani V; Szczepny A; Jayasekara WSN; Gonzalez-Rajal A; Kikuchi K; McCaughan GW; Burgess A; Gough DJ; Watkins DN; Cain JE
J Clin Invest; 2020 Aug; 130(8):4006-4018. PubMed ID: 32568216
[TBL] [Abstract][Full Text] [Related]
10. TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response.
Akeno N; Reece AL; Callahan M; Miller AL; Kim RG; He D; Lane A; Moulton JS; Wikenheiser-Brokamp KA
Mol Cancer Ther; 2017 Dec; 16(12):2913-2926. PubMed ID: 28847987
[TBL] [Abstract][Full Text] [Related]
11. A crucial requirement for Hedgehog signaling in small cell lung cancer.
Park KS; Martelotto LG; Peifer M; Sos ML; Karnezis AN; Mahjoub MR; Bernard K; Conklin JF; Szczepny A; Yuan J; Guo R; Ospina B; Falzon J; Bennett S; Brown TJ; Markovic A; Devereux WL; Ocasio CA; Chen JK; Stearns T; Thomas RK; Dorsch M; Buonamici S; Watkins DN; Peacock CD; Sage J
Nat Med; 2011 Oct; 17(11):1504-8. PubMed ID: 21983857
[TBL] [Abstract][Full Text] [Related]
12. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
Semenova EA; Kwon MC; Monkhorst K; Song JY; Bhaskaran R; Krijgsman O; Kuilman T; Peters D; Buikhuisen WA; Smit EF; Pritchard C; Cozijnsen M; van der Vliet J; Zevenhoven J; Lambooij JP; Proost N; van Montfort E; Velds A; Huijbers IJ; Berns A
Cell Rep; 2016 Jul; 16(3):631-43. PubMed ID: 27373156
[TBL] [Abstract][Full Text] [Related]
13. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.
Schaffer BE; Park KS; Yiu G; Conklin JF; Lin C; Burkhart DL; Karnezis AN; Sweet-Cordero EA; Sage J
Cancer Res; 2010 May; 70(10):3877-83. PubMed ID: 20406986
[TBL] [Abstract][Full Text] [Related]
14. Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset.
Febres-Aldana CA; Chang JC; Ptashkin R; Wang Y; Gedvilaite E; Baine MK; Travis WD; Ventura K; Bodd F; Yu HA; Quintanal-Villalonga A; Lai WV; Egger JV; Offin M; Ladanyi M; Rudin CM; Rekhtman N
Clin Cancer Res; 2022 Nov; 28(21):4702-4713. PubMed ID: 35792876
[TBL] [Abstract][Full Text] [Related]
15.
Jia D; Augert A; Kim DW; Eastwood E; Wu N; Ibrahim AH; Kim KB; Dunn CT; Pillai SPS; Gazdar AF; Bolouri H; Park KS; MacPherson D
Cancer Discov; 2018 Nov; 8(11):1422-1437. PubMed ID: 30181244
[No Abstract] [Full Text] [Related]
16. Targeted Inhibition of the E3 Ligase SCF
Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
[TBL] [Abstract][Full Text] [Related]
17. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
[TBL] [Abstract][Full Text] [Related]
18. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.
Meuwissen R; Linn SC; Linnoila RI; Zevenhoven J; Mooi WJ; Berns A
Cancer Cell; 2003 Sep; 4(3):181-9. PubMed ID: 14522252
[TBL] [Abstract][Full Text] [Related]
19. Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer.
Finlay JB; Ireland AS; Hawgood SB; Reyes T; Ko T; Olsen RR; Abi Hachem R; Jang DW; Bell D; Chan JM; Goldstein BJ; Oliver TG
Cancer Cell; 2024 Jun; 42(6):1086-1105.e13. PubMed ID: 38788720
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype relationships in a mouse model for human small-cell lung cancer.
Calbó J; Meuwissen R; van Montfort E; van Tellingen O; Berns A
Cold Spring Harb Symp Quant Biol; 2005; 70():225-32. PubMed ID: 16869758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
